+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides

Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides

Vaccine 28(39): 6425-6435

A phage display peptide library was screened using a panel of antibodies to the capsular polysaccharides of Streptococcus agalactiae and Neisseria meningitidis. Mimotopes NPDHPRVPTFMA (2-8), LIPFHKHPHHRG (3-2) and EQEIFTNITDRV (G3) showing the highest binding capacity and strongest ELISA reaction were selected for immunization experiments. These mimotopes were either synthesised as oligodeoxynucleotides for DNA immunization or MAP (multiple antigen peptide) for peptide immunization. Mimotope-DNA vaccination, particularly for G3, induced antibodies recognizing a number of target bacteria. This response was seen after the second boost injection and was significantly enhanced by the 3rd boost injection with a Th1-associated profile, which was dominated by IgG2a, followed by IgG1. Mimotope-MAP immunization also produced strong humoral immune responses to the bacteria. Antibodies from G3 DNA immunization reacted with the surface molecules of S. agalactiae, N. meningitidis and Escherichia coli K5 shown by indirect immunofluorescence staining, indicating a possible localization to the bacterial capsule. Antibodies produced both from DNA/MAP immunization reacted with purified bacterial capsular polysaccharides by ELISA and were of high avidity. We have further characterized peptide G3 by a 'tiling path' study to examine the effect of changing individual residues in the peptide in raising antibodies, which showed that the EIFTN motif in G3 was important in generating antibodies to several capsulated bacteria. We conclude that mimotope immunization with DNA or MAP potentially induces strong antibody responses against encapsulated bacteria. It is suggested that the antibody targets are polysaccharides, and these antibodies may cross react at least among closely related species of bacteria.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056829767

Download citation: RISBibTeXText

PMID: 20674874

DOI: 10.1016/j.vaccine.2010.07.049

Related references

Vaccination with trastuzumab mimotopes elicits antibodies recognizing Her-2/neu. Breast Cancer Research and Treatment 82(Suppl. 1): S113, 2003

Developing Peptide Mimotopes of Capsular Polysaccharides and Lipopolysaccharides Protective Antigens of Pathogenic Burkholderia Bacteria. Monoclonal Antibodies in Immunodiagnosis and ImmunoTherapy 35(3): 125-134, 2016

Peptide mimotopes of pneumococcal capsular polysaccharide of 6B serotype: a peptide mimotope can bind to two unrelated antibodies. Journal of Immunology 168(12): 6273-6278, 2002

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. European Journal of Immunology 36(5): 1267-1274, 2006

Anti idiotypic antibodies to bacterial capsular polysaccharides. Cerny, J And J Hiernaux (Ed ) Idiotypic Network And Diseases Xi+234p American Society For Microbiology: Washington, D C , Usa Illus 107-120, 1990

Immune-protective antibodies against capsular polysaccharides do not affect natural competence of Streptococcus pneumoniae: implications for current conjugate vaccination strategies?. FEMS Immunology and Medical Microbiology 29(3): 183-185, 2000

Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide. Yonsei Medical Journal 45(4): 755-758, 2004

Stereochemical aspects of the antigenic determinants of bacterial polysaccharides: The Rhodococcus equi capsular polysaccharides. Carbohydrate Polymers 25(4): 253-267, 1994

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine 18(13): 1218-1226, 2000

Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: Alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG. Journal of Clinical Immunology 20(2): 138-149, 2000

New nmr methods for the structural determination of bacterial capsular polysaccharides application to neisseria meningitidis escherichia coli cross reactive polysaccharides. Abstracts of Papers American Chemical Society 191, 1986

Sinorhizobium meliloti produces distinct capsular polysaccharides under free-living and symbiotic conditions. 2006

Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nature Biotechnology 17(7): 660-665, 1999

Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F. Infection and Immunity 69(2): 853-864, 2001

Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using Pneumovax-specific antibodies as a reference. Tohoku Journal of Experimental Medicine 161(3): 209-215, 1990